- Home
- SLRX vs CRNX Comparison
SLRX vs CRNX Comparison
Compare SLRX & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- CRNX
- Stock Information
- Founded
- SLRX N/A
- CRNX 2008
- Country
- SLRX United States
- CRNX United States
- Employees
- SLRX N/A
- CRNX N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- SLRX Health Care
- CRNX Health Care
- Exchange
- SLRX Nasdaq
- CRNX Nasdaq
- Market Cap
- SLRX 3.6M
- CRNX 2.8B
- IPO Year
- SLRX N/A
- CRNX 2018
- Fundamental
- Price
- SLRX $2.57
- CRNX $40.49
- Analyst Decision
- SLRX
- CRNX Buy
- Analyst Count
- SLRX 0
- CRNX 12
- Target Price
- SLRX N/A
- CRNX $74.45
- AVG Volume (30 Days)
- SLRX 154.6K
- CRNX 1.2M
- Earning Date
- SLRX 11-10-2025
- CRNX 11-06-2025
- Dividend Yield
- SLRX N/A
- CRNX N/A
- EPS Growth
- SLRX N/A
- CRNX N/A
- EPS
- SLRX N/A
- CRNX N/A
- Revenue
- SLRX N/A
- CRNX $1,392,000.00
- Revenue This Year
- SLRX N/A
- CRNX $405.68
- Revenue Next Year
- SLRX N/A
- CRNX $1,034.87
- P/E Ratio
- SLRX N/A
- CRNX N/A
- Revenue Growth
- SLRX N/A
- CRNX 0.51
- 52 Week Low
- SLRX $2.82
- CRNX $24.10
- 52 Week High
- SLRX $108.00
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- SLRX 29.78
- CRNX 44.22
- Support Level
- SLRX $3.55
- CRNX $41.41
- Resistance Level
- SLRX $3.97
- CRNX $43.89
- Average True Range (ATR)
- SLRX 0.33
- CRNX 1.94
- MACD
- SLRX -0.14
- CRNX -0.41
- Stochastic Oscillator
- SLRX 3.16
- CRNX 17.99
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.